Successful Pregnancy Outcome With Preconception Care in a Symptomatic Carrier of Duchenne Muscular Dystrophy: Case Report and Literature Review
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63926 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Motoaki Kinugawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Preconception Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Duchenne Muscular Dystrophy (DMD) is an X‐linked recessive disorder. Female carriers can manifest symptoms during pregnancy, complicating diagnosis and genetic counseling before conception. This is the first report of a DMD symptomatic carrier who was managed continuously from preconception through pregnancy for symptoms recognized before conception. A 31‐year‐old primipara woman was incidentally noted to have premature ventricular contractions, heart failure, and elevated creatine kinase levels 2 years before pregnancy. Genetic testing confirmed that the patient was a symptomatic carrier of DMD. She had no family history of muscular or cardiac disease, suggesting a de novo variant. She received genetic counseling and planned amniocentesis during pregnancy as prenatal diagnosis. After treatment with bisoprolol and flecainide, her cardiac function improved, and natural conception was achieved. Amniocentesis performed at 16 weeks of gestation indicated a 46, XX karyotype, leading to the decision to continue the pregnancy. From week 16 to 21, the fetus exhibited bradycardia due to blocked premature atrial contraction, which later improved, although the atrioventricular interval was prolonged. The mother delivered vaginally without any complications, and the infant's atrioventricular interval normalized. Preconceptional diagnosis and treatment for DMD carrier status are crucial for shared decision‐making and to achieve favorable perinatal outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Pediatrics, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Mari Ichinose
Zitieren
APA
Kinugawa, M., Ichinose, M., Matsui, H., Xiang, Z., Sayama, S., Toshimitsu, M., Seyama, T., Masuda, H., Matsui, H., Kumasawa, K., Iriyama, T., Hirota, Y., & Osuga, Y. (2025). Successful Pregnancy Outcome With Preconception Care in a Symptomatic Carrier of Duchenne Muscular Dystrophy: Case Report and Literature Review. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63926
Vancouver
Kinugawa M, Ichinose M, Matsui H, Xiang Z, Sayama S, Toshimitsu M, et al. Successful Pregnancy Outcome With Preconception Care in a Symptomatic Carrier of Duchenne Muscular Dystrophy: Case Report and Literature Review. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63926
BibTeX
@article{Kinugawa2025,
author = {Kinugawa, Motoaki and Ichinose, Mari and Matsui, Haruka and Xiang, Zeng and Sayama, Seisuke and Toshimitsu, Masatake and Seyama, Takahiro and Masuda, Hitomi and Matsui, Hikoro and Kumasawa, Keiichi and Iriyama, Takayuki and Hirota, Yasushi and Osuga, Yutaka},
title = {Successful Pregnancy Outcome With Preconception Care in a Symptomatic Carrier of Duchenne Muscular Dystrophy: Case Report and Literature Review},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63926}
}
EUVIMED